Order Article Reprints

Damiani G, Odorici G, Pacifico A, Morrone A, Conic RRZ, Davidson T, Watad A, Pigatto PDM, Colombo D, Malagoli P, et al. Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic Patients That Avoided Secukinumab Switching. Pharmaceuticals. 2022; 15(1):95. https://doi.org/10.3390/ph15010095

Damiani, Giovanni, Giulia Odorici, Alessia Pacifico, Aldo Morrone, Rosalynn R. Z. Conic, Tima Davidson, Abdulla Watad, Paolo D. M. Pigatto, Delia Colombo, Piergiorgio Malagoli, and et al. 2022. "Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic Patients That Avoided Secukinumab Switching" Pharmaceuticals 15, no. 1: 95. https://doi.org/10.3390/ph15010095

Damiani, G., Odorici, G., Pacifico, A., Morrone, A., Conic, R. R. Z., Davidson, T., Watad, A., Pigatto, P. D. M., Colombo, D., Malagoli, P., & Fiore, M. (2022). Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic Patients That Avoided Secukinumab Switching. Pharmaceuticals, 15(1), 95. https://doi.org/10.3390/ph15010095